Navigation Links
New data demonstrate potential for early detection of Alzheimer's disease
Date:6/16/2009

MONTREAL, CANADA, JUNE 16, 2009 Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease. There is currently no accepted laboratory test for diagnosing Alzheimer's disease.

Researchers at McGill University and the Lady Davis Institute for Medical Research (LDI) at the Jewish General Hospital (Montreal, Canada), have shown that near-infrared (NIR) biospectroscopy can identify a chemical signature, or biomarker, in blood that distinguishes Alzheimer's disease from normal aging and possibly other neurodegenerative conditions. Diagnosis of Alzheimer's disease is currently based solely on a patient's medical history and neurological examination, is labor-intensive and expensive, and often inconclusive in early stages of the illness. The availability of a biologic marker that reliably differentiates Alzheimer's disease from normal aging and other dementing conditions would represent a major achievement in the management of this common neurodegenerative disorder.

"There is an urgent need for an accurate diagnostic test to aid in the early diagnosis and management of Alzheimer's disease," said Hyman M. Schipper, MD, PhD, FRCPC, lead author of the study and Professor of Neurology and Medicine at McGill University. Dr. Schipper is also Founding Director of the Centre for Neurotranslational Research and a member of the Bloomfield Centre for Research in Aging at the LDI. "Our observations give us hope that biospectroscopy will offer a new approach to the early diagnosis of Alzheimer's disease and other neurodegenerative disorders." Dr. Schipper is a noted expert in brain aging and neurodegeneration. Dr. David Burns of the Department of Chemistry at McGill University, an experienced biospectroscopist, was a co-investigator of the study.

In this study, an NIR biospectroscopy analysis was conducted on blood plasma samples from a total of 63 subjects, 19 with Alzheimer's disease, 27 with mild cognitive impairment (a frequent indication of Alzheimer's disease) and 17 normal elderly controls, to measure the degree of oxidative stress in plasma. OS is caused by a chemical imbalance that can damage critical components of cells and biofluids, including proteins, lipids and DNA. OS is known to be involved in many neurological diseases, including Alzheimer's and Parkinson's disease.

In differentiating Alzheimer's disease patients from the normal elderly control group, NIR achieved a sensitivity of 80% and specificity of 77%. Fifteen and twelve patients with mild cognitive impairment were classified with the normal elderly control group and Alzheimer's disease groups, respectively.

"These results demonstrate the potential for NIR biospectroscopy to differentiate mild, and possibly pre-clinical, Alzheimer's disease from normal aging with high accuracy," Dr. Schipper added. "We are very encouraged by these data and look forward to testing this potential diagnostic tool in larger-scale studies."

"Near-Infrared Spectroscopy of Blood Plasma for Diagnosis of Sporadic Alzheimer Disease," was published in Journal of Alzheimer's Disease, 17:2 (June 2009).

Near-infrared spectroscopy is commonly used in medical diagnostics, food and agrochemical quality control, as well as combustion research.

This technology has been licensed to Molecular Biometrics, Inc., a metabolomics company specializing in the development of minimally-invasive biomarkers for Alzheimer's disease, Parkinson's disease and assisted reproduction.


'/>"/>

Contact: Gina Cella
ginacella@comcast.net
781-334-4692
IOS Press
Source:Eurekalert

Related medicine news :

1. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
2. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
3. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
4. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
5. Highmarks Hospital Pay-for-Performance Program Demonstrates Impressive Results
6. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
7. STA Travel and Keep a Child Alive Ask College Students to Demonstrate Their Good Cents
8. LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery
11. New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate ... in 2017 who are passionate about making a difference in the lives of ... in Tampa, UMA, a nonprofit healthcare educational institution, has more than 30,000 alumni ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sam & Associates Insurance ... commercial and residential clients in the California Bay Area, is launching a charity drive ... the region. , Heart disease is the primary killer of adult men and women ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Tribble Insurance ... to the eastern Virginia region, is inaugurating a charity event to honor Chad Phillip ... While on duty last year, Chad Phillip Dermyer and his fellow officers were conducting ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... St. Catherine’s ... Center. , Siena Center is a skilled nursing facility on the grounds of the ... semiprivate rooms. It recently was voted the best nursing home in Mississippi for the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Spring Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries ... . , Educational grants totaling $15,000 will be awarded for the best ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 18, 2017 The Global ... understanding and access to partnering deals and agreements entered ... Trends in partnering deals - Top deals by value ... of development, technology type The report provides understanding ... into by the world,s leading healthcare companies. The ...
(Date:1/19/2017)... Jan. 18, 2017 The Academy of ... Drug Administration (FDA) for its release today of ... health decision makers can proactively share clinical and ... well as emerging therapies awaiting FDA approval. ... recommendations that AMCP developed during two multi-stakeholder meetings ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 ... "Breast Imaging Technologies Market by Type: Global Opportunity Analysis and ... market size was valued at $2,544 million in 2015 and ... a CAGR of 8.4% from 2016 to 2022. ... together accounted for over three-fourths market share in 2015. Ionizing ...
Breaking Medicine Technology: